New Rite Aid, LLC
RADDelisted Oct 31, 2023- Industry
- Retail-Drug Stores and Proprietary Stores
- SEC CIK
- 0000084129
New Rite Aid, LLC was delisted on Oct 31, 2023; its insiders filed their last Form 4 on Jul 28, 2023; 94 institutions reported holding it in 13F filings for Q3 2023, worth $7.55M in total; no superinvestor held it.
- Currency
- USD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Oct 8, 2026, 11:15 AM ET
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|
| Period end | Mar 4, 2023 | Feb 26, 2022 | Feb 27, 2021 | Feb 29, 2020 | Mar 2, 2019 |
| Filing | 10-K/A | 10-K | 10-K | 10-K | 10-K |
| Reported | Apr 20, 2023 | Apr 14, 2022 | Apr 15, 2021 | Mar 16, 2020 | Apr 11, 2019 |
| Revenue | $24.1B | $24.6B | $24.0B | $21.9B | $21.6B |
| Cost of revenue | $19.3B | $19.5B | $19.3B | $17.2B | $17.0B |
| Gross profit | $4.80B | $5.11B | $4.70B | $4.73B | $4.68B |
| Selling, general and administrative | $4.90B | $5.03B | $4.66B | $4.59B | $4.59B |
| Interest expense | $224.4M | $191.6M | $201.4M | $229.7M | $227.7M |
| Income tax | -$6.47M | -$3.78M | -$20.2M | $387.6M | $77.5M |
| Net income | -$719.2M | -$538.5M | -$90.9M | -$452.2M | -$422.2M |
| EPS, basic | $-13.15 | $-9.96 | $-1.69 | $-8.50 | $-7.99 |
| EPS, diluted | $-13.15 | $-9.96 | $-1.69 | $-8.50 | $-7.99 |
| Weighted shares, basic | 54.7M | 54.1M | 53.7M | 53.2M | 52.9M |
| Weighted shares, diluted | 54.7M | 54.1M | 53.7M | 53.2M | 52.9M |
| Margins and growth | |||||
| Gross margin | 19.9% | 20.8% | 19.6% | 21.6% | 21.6% |
| Net margin | -3.0% | -2.2% | -0.4% | -2.1% | -2.0% |
| Revenue growth, year over year | −1.9% | +2.2% | +9.6% | +1.3% | +0.5% |
| Net income growth, year over year | – | – | – | – | −144.8% |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|
| Period end | Mar 4, 2023 | Feb 26, 2022 | Feb 27, 2021 | Feb 29, 2020 | Mar 2, 2019 |
| Filing | 10-K/A | 10-K | 10-K | 10-K | 10-K |
| Reported | Apr 20, 2023 | Apr 14, 2022 | Apr 15, 2021 | Mar 16, 2020 | Apr 11, 2019 |
| Cash and equivalents | $157.2M | $39.7M | $160.9M | $218.2M | $144.4M |
| Accounts receivable | $1.15B | $1.34B | $1.46B | $1.29B | $1.79B |
| Inventory | $1.90B | $1.96B | $1.86B | $1.92B | $1.87B |
| Total current assets | $3.30B | $3.45B | $3.60B | $3.70B | $4.10B |
| Property, plant and equipment | – | – | – | $1.22B | $1.31B |
| Goodwill | $507.9M | $879.1M | $1.11B | $1.11B | $1.11B |
| Intangible assets | $250.1M | $291.2M | $340.5M | $359.5M | $448.7M |
| Total assets | $7.53B | $8.53B | $9.34B | $9.45B | $7.59B |
| Accounts payable | $1.49B | $1.57B | $1.44B | $1.48B | $1.62B |
| Short-term debt | – | – | $6.41M | $8.84M | $16.1M |
| Total current liabilities | $2.71B | $2.93B | $2.60B | $2.77B | $2.44B |
| Long-term debt | $2.93B | $2.73B | $3.06B | $3.08B | $3.45B |
| Total liabilities | $8.12B | $8.43B | $8.72B | $8.78B | $6.40B |
| Shareholders' equity | -$594.2M | $99.0M | $615.2M | $674.5M | $1.19B |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|
| Period end | Mar 4, 2023 | Feb 26, 2022 | Feb 27, 2021 | Feb 29, 2020 | Mar 2, 2019 |
| Filing | 10-K/A | 10-K | 10-K | 10-K | 10-K |
| Reported | Apr 20, 2023 | Apr 14, 2022 | Apr 15, 2021 | Mar 16, 2020 | Apr 11, 2019 |
| Capital expenditures | $215.3M | $194.1M | $195.1M | $171.7M | $196.8M |
| Depreciation and amortization | $276.6M | $295.7M | $327.1M | $328.3M | $357.9M |
| Stock-based compensation | $11.5M | $13.1M | $13.0M | $16.1M | $12.1M |
| Net change in cash | $117.4M | -$121.2M | -$57.3M | $73.8M | -$303.0M |
| Ratio | |||||
| Stock-based compensation, % of revenue | 0.0% | 0.1% | 0.1% | 0.1% | 0.1% |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
| Cover date | Shares outstanding | Change in a year | Filing |
|---|---|---|---|
| Jul 22, 2024 | 56.0M | −1.3% | SEC |
| Oct 3, 2023 | 56.5M | 0.0% | SEC |
| Jun 28, 2023 | 56.7M | +1.9% | SEC |
| Apr 12, 2023 | 56.4M | +1.4% | SEC |
| Dec 20, 2022 | 56.5M | +1.3% | SEC |
| Sep 24, 2022 | 56.5M | +1.4% | SEC |
| Jun 22, 2022 | 55.6M | +1.0% | SEC |
| Apr 13, 2022 | 55.6M | +1.0% | SEC |
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.